POPDC3
protein-codingpopeye domain containing 3
Gene summary
This gene encodes a member of the POP family of proteins containing three putative transmembrane domains. This gene is expressed in cardiac and skeletal muscle and may play an important role in these tissues during development. Alternatively spliced transcript variants have been found. [provided by RefSeq, Nov 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~22.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030014
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0030014
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0015152
Submitter: ClinGen
*POPDC3* (Popeye Domain-Containing Protein 3) was first reported in relation to autosomal recessive limb-girdle muscular dystrophy (LGMD) in 2019 (Vissing et al., PMID: 31610034). *POPDC3* is a Popeye domain-containing protein that is abundantly expressed in heart and skeletal muscle. Autosomal recessive LGMD (MONDO:0015152) is characterized by adult-onset weakness primarily affecting the proximal muscles of the lower limbs. Seven homozygous probands from seven families have been described in five publications (PMID: 31610034, 35842834, 35075722, 37104941, 41026953; 9.8 pts). Co-segregation with the LGMD phenotype was observed in affected siblings in two families. Reported variants include two unique splice variants, one stop-gained variant, and four unique missense variants (9.8 pts). Three of the missense variants were shown to impair regulation of TREK-1 current in Xenopus oocytes, but the significance of this effect with respect to the disease mechanism is considered unclear. The mechanism for disease is though to be biallelic loss of function, but the exact pathogenic mechanisms are not yet known. This gene-disease association is also supported by experimental evidence (1.5 pts). POPDC3 is uniquely expressed in skeletal and cardiac muscle, providing evidence towards an association with this muscle-affecting disorder (PMID: 10882522), and co-IP studies have demonstrated a direct interaction between POPDC3 and *BVES* (*POPDC1*), which is definitively associated with autosomal recessive LGMD (PMID: 36624536). In addition, a zebrafish knock-out mutant model demonstrated ventral tail curvature and dystrophic changes in myofibers (PMID: 31610034), although a significant phenotype was not observed by early adulthood in homozygous knock-out mice (C57BL/6N-Popdc3tm1.1(KOMP)Vlcg/MbpMmucd; https://www.mmrrc.org/catalog/sds.php?mmrrc_id=49150). In summary, there is definitive evidence (11.3 pts) to support the relationship between *POPDC3* and autosomal recessive LGMD. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This gene-disease pair was originally evaluated by the MDM GCEP in May 2023. It was reevaluated in February 2025. As a result of this reevaluation, the classification was upgraded from Moderate to Definitive with the addition of an additional case and protein interaction data (PMID: 36624536, 41026953).
Inheritance Pattern: AR
Disease ID:MONDO:0030014
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to POPDC3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_022361.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 2 | 3 | |||
| missense | 4 | 33 | 1 | 1 | 39 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 5 | 1 | 36 | 2 | 3 | 47 |
Highest pathogenic variant AF is 0.000028502209
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_071756.2 | 3 | MANE Select | |
| Ensembl | ENSP00000254765.3 | 3 | MANE Select | |
| Ensembl | ENSP00000414409.1 | 2 | Standard | |
| Ensembl | ENSP00000552252.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- heart development
- skeletal muscle tissue development
- biological_process
- regulation of membrane potential
- striated muscle cell differentiation
Molecular Function
- molecular_function
- cAMP binding
Cellular Component
- membrane
- integral component of membrane
- sarcolemma
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000254765
- Coding exons
- 3
- Length
- 21716
- Individuals with no LoFs
- 125715
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 24
- Defined
- 125739
- p
- 0.0000954
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.666 | 133 | 156 | 0.850 | 0.00000791 | 1898 |
| Missense (PolyPhen) | 50 | 62.902 | 0.79488 | 754 | ||
| Synonymous | -0.431 | 61 | 56.9 | 1.07 | 0.00000274 | 568 |
| Loss of Function | 1.81 | 5 | 11.7 | 0.429 | 6.43e-7 | 136 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00037 | 0.00037 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000088 | 0.000088 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in the maintenance of heart function mediated, at least in part, through cAMP-binding. {ECO:0000250|UniProtKB:Q9ES81, ECO:0000269|PubMed:10882522}.;
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- LoFtool
- 0.636
- RVIS EVS
- 0.24
- RVIS percentile EVS
- 69.21
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.324
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |